Temperature Dependence on Reversed- Phase Separations of Fatty Acid Modified GLP-1 Receptor Agonists and Their Impurities

Application Note Column Selection for RPLC-UV Impurity Analysis of Fatty Acid Modified GLP-1 Receptor Agonists Caitlin M. Hanna, Stephan M. Koza, Steve Shiner Waters Corporation Abstract Here, we screen four column chemistries for the RPLC-UV impurity analyses of liraglutide and…

Application Note Reversed-Phase LC-MS Analysis of LowAbundance Impurities in a GLP-1a Therapeutic Using a Charged Surface 230Å Superficially Porous Phenyl-Hexyl Column Stephan M. Koza, Stephen J. Shiner, Matthew A. Lauber Waters Corporation, United States Published on July 15, 2026 Abstract…

Application Note Comprehensive Characterization and Impurity Profiling of the GLP-1 Analogue Tirzepatide Using the Xevo™ G3 QTof High Resolution Mass Spectrometer Chris Henry, Isabella Jones Waters Corporation, United States Published on May 28, 2026 Abstract Forced degradation studies on glucagon-like…

Agilent biopharma solutions Workflows for GLP-1 Receptor Agonists and Therapeutic Peptides: Identity, Impurity, Bioanalysis, and Stability Testing Contents Raw Material Purity and Impurity Identification Analysis Bioanalysis Stability Testing Studies Contents Introduction 02 1 Raw Material Identification 03 1.1 Verification…